GLUCAGON SECRETION IN WELL CONTROLLED DIABETES MELLITUS
$321,374M01FY2001RRNIH
University Of Texas Sw Med Ctr/Dallas, Dallas TX
Investigators
Linked publications & trials
Paper 35728925Paper 34669075Paper 33478957Paper 32779294Paper 32111975Paper 31691959Paper 31427096Paper 31221698Paper 31005534Paper 30737489Paper 30631138Paper 29874658Paper 29872859Paper 28647272Paper 28283553Paper 28199816Paper 27455401Paper 27423510Paper 27074126Paper 26679435Paper 26080344Paper 25424574Paper 25213055Paper 24886531Paper 24665001Paper 24552753Paper 24378638Paper 24370654Paper 24344119Paper 24331012Paper 24325736Paper 24113734Paper 24067395Paper 24008162Paper 23867957Paper 23800548Paper 23783098Paper 23762536Paper 23687099Paper 23447519Paper 23418044Paper 23404728Paper 23219305Paper 23187859Paper 23139080Paper 23080496Paper 22990274Paper 22984143Paper 22939555Paper 22926660Paper 22811446Paper 22748517Paper 22739230Paper 22688849Paper 22644414Paper 22641777Paper 22571902Paper 22499082Paper 22359532Paper 22331415Paper 22297671Paper 22247230Paper 22170723Paper 22114147Paper 22100029Paper 22067724Paper 22065155Paper 22045670Paper 22002999Paper 21976719Paper 21946897Paper 21931376Paper 21930284Paper 21917261Paper 21829595Paper 21818156Paper 21817103Paper 21782771Paper 21760886Paper 21734082Paper 21699796Paper 21690484Paper 21681226Paper 21562061Paper 21555334Paper 21520194Paper 21508291Paper 21480316Paper 21440548Paper 21376050Paper 21374690Paper 21335007Paper 21257113Paper 21254377Paper 21232706Paper 21211932Paper 21139575Paper 21139111Paper 21136163Paper 21135351
Abstract
Aims are: 1) to evaluate the relationship between the level of antecedent diabetic control & development of small blood vessel complications; 2) to use skeletal muscle capillary basement membrane width as a marker for diabetes complications; 3) to use alternate methods of treating insulin dependent and non-insulin dependent diabetes mellitus; 4) to study insulin resistant diabetes mellitus.
View original record on NIH RePORTER →